Clinical trial
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and…
NCT00338091 · Southern Medical University, China, Other · Terminated
Key facts
| NCT number | NCT00338091 |
|---|---|
| Title | Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency |
| Lead sponsor | Southern Medical University, China, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Renal Insufficiency, Chronic, Disease Progression, Proteinuria, Dose-Response Relationship, Drug, ACE Inhibitor, Angiotensin II Type 1 Receptor Blockers |
| Intervention type | Drug |
| Interventions | Benazepril, Losartan |
| Start date | Jan 1, 2002 |
| Completion | May 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Jun 20, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: